LoginSignup
XVI

Xvivo Perfusion

Stock
Stock
ISIN: SE0004840718
Ticker: XVIVO
SE0004840718
XVIVO

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Xvivo Perfusion is $853.69M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Xvivo Perfusion is 93.46. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Xvivo Perfusion's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.29. EPS indicates the company's profitability on a per-share basis.
Currently, 6 analysts cover Xvivo Perfusion's stock, with a consensus target price of $35.70. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Xvivo Perfusion reported a revenue of $92.32M.
Xvivo Perfusion's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $19.10M. EBITDA measures the company's overall financial performance.
Xvivo Perfusion has a free cash flow of $24.37M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Xvivo Perfusion employs approximately 210 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Xvivo Perfusion is 25.13M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$853.69M
EPS (TTM) 
$0.29
Free Float 
25.13M
P/E ratio (TTM) 
93.46
Revenue (TTM) 
$92.32M
EBITDA (TTM) 
$19.10M
Free Cashflow (TTM) 
$24.37M

Pricing

1D span
$26.59$27.50
52W span
$16.77$33.73

Analyst Ratings

The price target is $35.70 and the stock is covered by 6 analysts.

Buy

6

Hold

0

Sell

0

Information

Xvivo Perfusion AB is a medical technology company operates in the field of organ transplantation technology. It involves in developing and marketing solutions and systems for assessing the usability of organs, and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex and Silicone Tubing Set. The company operates through the following segments: Thoracic, Abdominal and Services. The Thoracic segment engages in the sale of products for lung and heart transplantation. The Abdominal segment engages in the sale of products for liver and kidney transplantation. The Services segment engages in providing organ recovery-related services. The company was founded by Magnus Nilsson on December 17, 1998 and is headquartered in Gothenburg, Sweden.

Employees
210
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
SE0004840718
Primary Ticker
XVIVO

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin